Dr. Miyamoto's Publications (continued) Wu Z, Mabb A, and Miyamoto S. (2005). PIDD: a switch hitter. Cell. 123:980-982. PDF PMID 16360026 Berchtold CM, Chen K-S, Miyamoto S, and Gould MN. (2005). Perillyl alcohol inhibits a calcium-dependent constitutive NF-kB pathway. Cancer Res. 65:8558-8566. PDF PMID 16166337 Wuerzberger-Davis SM, Chang P-Y, Berchtold C, and Miyamoto S. (2005). Enhanced G2/M arrest by NF-kB-dependent p21waf1/cip1 induction. Mol Cancer Res. 3:345-353. PDF PMID 15972853 O'Connor S and Miyamoto S. (2005). Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor resistant (PIR) IkBa degradation. Exp Cell Res. 307:15-25. PDF PMID 15922723 O'Connor S, Shumway S, and Miyamoto S. (2005). Inhibition of IkBa nuclear export as an approach to abrogate NF-kB dependent cancer cell survival. Mol Cancer Res. 3:42-49. PDF PMID 15671248 Miyamoto S. (2004). RelA life and death decisions. Mol Cell. 13:763-764. PDF PMID 15053867 Bates P and Miyamoto S. (2004) Expanded nuclear roles for IkB's. Science STKE. 254:48. PMID 15479861 O'Connor S, Shumway SD, and Miyamoto S. (2004). Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkBa degradation in B cells. Mol Cell Biol. 24:4895-4908. PDF PMID 15143182 Huang TT, Davis SM, Wu Z, and Miyamoto S. (2003). Sequential modification of NEMO/IKKg by SUMO-1 and ubiquitin mediates NF-kB activation by nuclear DNA damage. Cell. 115:565-576.  PMID: 14651848 (News and Views: Hay RT. (2004). Modifying NEMO. Nature Cell Biol. 6:89-91.